Mild to Moderate Atopic Dermatitis

Immunology

Prevalence

3285.9 / 100K

Incidence

416.4 / 100K/yr

1 drug in development·1 company·1 clinical trial

Drug Pipeline by Phase

Frequently asked questions

How many drugs are in development for Mild to Moderate Atopic Dermatitis?

BioSniper tracks 1 drug in development for Mild to Moderate Atopic Dermatitis across 1 company.

How many clinical trials target Mild to Moderate Atopic Dermatitis?

There are 1 clinical trial targeting Mild to Moderate Atopic Dermatitis tracked by BioSniper.

What is the prevalence of Mild to Moderate Atopic Dermatitis?

The estimated prevalence of Mild to Moderate Atopic Dermatitis is approximately 3285.9 per 100,000 population.

Deep-dive into Mild to Moderate Atopic Dermatitis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Mild to Moderate Atopic Dermatitis — Drugs in Development & Clinical Trials | BioSniper